Pharmaion consultant offers latest market research report brochure for hospital acquired infections prevention market in United States. So find latest analysis and market overview for "United states hospital acquired infections prevention"..

1. India Adhesives Market
Forecast & Opportunities, 2020
P h a r m a & H e a l t h c a r e C o n s u l t a n t s
United States Hospital -acquired Infections
Prevention Market Opportunities, 2010 -2020

2. 2
R e s e a r c h M e t h o d o l o g y
© Pharmaion
Primary Research
•Identifying Key Opinion Leaders
•Questionnaire Design
•In-depth Interviews
•Coverage across Value Chain market
Market Estimation & Forecasting
Bottom-Up or Top-down approach for Market size estimation
Historical trend examination
Impact analysis of drivers and challenges to market growth
Statistical evaluation to develop the actual forecast
Data Validation, Analysis and Interpretation
Data validation through Primary & Secondary outreach, data analysis and
interpretation of key findings
Preliminary Data Mining
Qualitative and Quantitative research
2015E 2016F 2017F 2018F 2019F 2020F
CAGR (2015E-2020F): XX%
US Hospital-acquired Infections
Prevention Market Opportunities, 2020 Secondary Research
•Government websites
•Company annual reports, white
papers, investor presentations and
financial reports

3. 3
R e s e a r c h M e t h o d o l o g y
© Pharmaion
Baseline Methodology:
For the study of the United States hospital-acquired infections prevention market, Pharmaion has gathered
information through an exhaustive search of credible databases prudently evaluated all the collected information
and presented it in the most accurate and detailed manner.
Primary Sources
Key Stakeholders:
 Product/Brand Managers
 Business Development
Managers
 Regional Mangers
 Regulatory Affairs Personnel
 Marketing & Sales Managers
 Head of Patient Support
Programme
Substantial data points for analysis,
interpretation and market size estimation
Data
Triangulation
(Data
validation
through cross
verification
from primary
& secondary
sources)
Qualitative and
quantitative data
from company
website, financial
reports, research
articles, designed
questionnaires
etc.
In-depth
interviews of key
stakeholders of
major companies
Secondary Sources
Analysis of Data from credible
sources:
 Centers for Disease Control
and Prevention (CDC)
 American Cancer Institute
 American Hospital Directory

4. Calculation of Sub- segment
market size
4
R e s e a r c h M e t h o d o l o g y
© Pharmaion
United States Hospital-acquired Infections Prevention Market - Market Size Estimation
 United States Hospital-acquired Infections Prevention market has been segmented into two categories:
Disinfection and Sterilization
 Sterilization has been further categorized into three sub-segments: Equipment, Services, and
Consumables
 Disinfection has been further classified into six sub segments: Disinfection Robots, Disinfectants,
Endoscope Reprocessors, Disinfectors, Wipes, and Personal-use Non-wovens.
Calculation of United
States Sterilization for
Hospital-acquired
Infections Prevention
Market Size
Top-downApproach
Bottom-upApproach
Calculation
of Sub-
segment
market size
Calculation
of United
States
Disinfection
for Hospital-
acquired
Infections
Prevention
Market Size
Total Market Size =
Sterilization Market
Size + Disinfection
Market Size
Regional & Company
Market Size =
Respective Market
Share (from primary
and secondary
research) X Total
Market Value

5. 5
Ta b l e o f C o n t e n t s
© Pharmaion
S No. Contents
1. Hospital-acquired Infections Prevention Overview
2. Research Methodology
3. Analyst View
4. Global Hospital-acquired Infections Prevention Market Overview
5. United States Hospital-acquired Infections Prevention Market Outlook
5.1. Market Size and Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Prevention Type
5.2.2. By Region
5.2.3. By Company
6. United States Sterilization for Hospital-acquired Infections Prevention Market Outlook
6.1. Market Size and Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
7. United States Disinfection for Hospital-acquired Infections Prevention Market Outlook
7.1. Market Size and Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type

6. 6
Ta b l e o f C o n t e n t s
© Pharmaion
S No. Contents
8. Market Dynamics
8.1. Drivers
8.2. Challenges
9. Market Trends & Developments
9.1. UV Disinfecting Robots – Future of Disinfection
9.2. Plummeting Surgical Site Infections
9.3. RFID – Technology for Monitoring Hand Hygiene
9.4. Gas Plasma Sterilization Technology
9.5. Hospital Infection Prevention from Digital Technology
10. Regulatory Framework and Guidelines
10.1. Deficit Reduction Act of 2005
10.2. Guidelines
11. United States Economic Profile
12. Competitive Landscape
12.1. Competition Benchmarking
12.2. Company Profiles
12.2.1. Steris Corporation
12.2.2. Advanced Sterilization Products
12.2.3. Getinge USA, Inc.
12.2.4. 3M Company
12.2.5. Belimed
12.2.6. Cantel Medical Corp.

7. 7
Ta b l e o f C o n t e n t s
© Pharmaion
S No. Contents
12.2.7. Halyard Health, Inc.
12.2.8. Cisa America Inc.
12.2.9. Cardinal Health, Inc.
12.2.10. Tuttnauer USA Co. Ltd.
13. Strategic Recommendations
14. About Us & Disclaimer

8. I n d u s t r y B r i e f
8
© Pharmaion
United States Hospital-acquired Infections Prevention Market to Grow at Over 7% Until 2020
Growing incidence of hospital-acquired infections and stringent government policies to drive the United States
hospital-acquired infections prevention market through 2020
According to recently published Pharmaion report,“United States Hospital-acquired Infections Prevention Market
Opportunities, 2010 - 2020”, hospital-acquired infections prevention market in the United States is projected to
grow at a CAGR of over 7% during 2015 - 2020. Growth in the US hospital-acquired infections prevention market
can be attributed to growing incidence of hospital-acquired infections and rising prevalence of chronic diseases
among geriatric population. Moreover, implementation of stringent laws against hospitals with regards to hospital-
acquired infections, under the Deficit Regulation Act, 2005,is also anticipated to drive demand for hospital-
acquired infections prevention market in the United States during 2015 - 2020.
On the basis of prevention type, the market has been segmented into two categories, namely, sterilization and
disinfection. Among these categories, sterilization segment dominated the United States hospital-acquired
infections prevention market in 2014, and is anticipated to continue its dominance during forecast period on
account of its high efficiency and capability to clean and kill microorganisms in extreme corners of medical devices
used in diagnostic and treatment procedures. South region accounted for the largest share in the United States
hospital-acquired infections prevention market in 2014, followed by the Midwest, West and North-East regions.
“With increasing adoption of UV disinfecting robots and RFID, a technology for monitoring hand hygiene, coupled
with growing adoption of gas plasma sterilization technology, the market for hospital-acquired infections
prevention market in the United States is anticipated to grow at a robust pace over the next five years. Moreover,
Office of Disease Prevention and Health Promotion (ODPHP) and US Department of Health and Human Services
(HHS) developed the “National Action Plan to Prevent Health Care-Associated Infections: Road Map to
Elimination” in 2009. This plan was focused to prevent hospital-acquired infections across all health care settings,
including acute care hospitals, ambulatory surgical centres, end-stage renal disease facilities and long-term care
facilities.” said Mr. Karan Chechi, Research Director, with Pharmaion Consultants, a research based global
pharmaceutical and healthcare consulting firm.

9. 9
Hospital-acquired infection, also known as nosocomial infection, is defined as an infection whose development
takes place in a favourable hospital environment, specifically those which are acquired by a patient during a
hospital visit and often develop among the hospital staff.
Hospital-acquired infections majorly leads to severe pneumonia and infections of bloodstream, urinary tract
and other parts of the body.
© Pharmaion
Hospital-acquired Infections
SSI, 20%
CAUTI, 20%
HO-HCFA CDI,
20%
CLABSI, 20%
VAP, 20%
United States Hospital-acquired Infections Share, 2013
Abbreviations Used:
XXXX
XXXX
XXXX
XXXX
XXXX
H o s p i t a l - a c q u i r e d I n f e c t i o n s P r e v e n t i o n O v e r v i e w

10. 10
S a m p l e D a t a - S n a p s h o t
© Pharmaion
United States Hospital-acquired Infections Prevention
Market Size, By Value, 2010-2020F (USD Billion)
1 2 3 4 5 6 7 8 9 10 11
1 2 3 4 5 6 7 8 9 10
United States Number of Deaths from
10 Leading Causes, 2013
Surgical Site
Infections, 20.0%
Ventilator-
associated
Pneumonia, 20.0%
Central line-
associated
bloodstream
infection,
20.0%
C. Difficile
Infections,
20.0%
Catheter-
associated
UTIs, 20.0%
United States Costs of Commonly Hospital-acquired
Infections Diagnosis & Treatment, 2012 (%)
1
2
3
4
5
2010 2011 2012 2013 2014
North-East Region
1
2
3
4
5
2010 2011 2012 2013 2014
West Region
1
2
3
4
5
2010 2011 2012 2013 2014
Midwest Region
1
2
3
4
5
2010 2011 2012 2013 2014
South Region
United States Hospital-acquired Infections Prevention Market
Size, By Region, By Value, 2010-2014 (USD Million)
United States Hospital-acquired Infections Prevention Market Share, By
Company, By Value, 2010-2020F
30.1% 30.2% 30.3% 30.4% 30.5% 30.6% 30.7% 30.8% 30.9% 31% 31.1%
5% 5.1% 5.2% 5.3% 5.4% 5.5% 5.6% 5.7% 5.8% 5.9% 6%
14% 14.1% 14.2% 14.3% 14.4% 14.5% 14.6% 14.7% 14.8% 14.9% 15%
16% 16.1% 16.2% 16.3% 16.4% 16.5% 16.6% 16.7% 16.8% 16.9% 17%
31% 31.1% 31.2% 31.3% 31.4% 31.5% 31.6% 31.7% 31.8% 31.9% 32%
2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F
Others 3M Company Getinge USA Inc.
ASP Steris Corporation

11. 11
R e p o r t O r d e r i n g
License Type Price
Single User License $2500
Single User License Print $3000
Enterprise License $5000
To View Sample OR Purchase Report
Report Price
Report Name: United States Hospital-acquired Infections Prevention
Market Opportunities, 2010-2020
© Pharmaion

12. 12
A b o u t U s & D i s c l a i m e r
NORTH AMERICA
Pharmaion Consultants LLC
708 3RD Avenue, 6th Floor, New York, NY,
United State, 10017
sales@pharmaion.com
+1 646 360 1656
www.pharmaion.com
About Us :
Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry.
Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customers
with high value market research and advisory services that helps them identify new market opportunities, growth engines and
innovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow market trends. Not bound by
legacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as
engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaion’s reports
do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them with
comprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trained
industry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consulting
requirements.
Related Reports
United States Autoimmune Disorders Diagnostics Market Opportunities, 2020
Global Tissue Engineered Medical Devices Market Opportunities, 2020
Global Cervical Cancer Vaccine Market Opportunities, 2020
Disclaimer :
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made
that it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained from
various sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee the accuracy, adequacy or
completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and
especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates
and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s
internal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants.
ASIA PACIFIC
Pharmaion Consultants Pvt. Ltd.
A – 51, Sector 57, Noida, National Capital Region,
India - 201301
sales@pharmaion.com
+91 - 120 - 452 3900
www.pharmaion.com
© Pharmaion